Opportunity ID: 286802

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DK-16-509
Funding Opportunity Title: Limited Competition for the Continuation of Epidemiology of Diabetes Interventions and Complications (EDIC) Study Biostatistics Research Center (Collaborative U01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Food and Nutrition
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Aug 01, 2016
Last Updated Date:
Original Closing Date for Applications: Nov 08, 2016
Current Closing Date for Applications: Nov 08, 2016
Archive Date: Dec 09, 2016
Estimated Total Program Funding:
Award Ceiling: $2,500,000
Award Floor:

Eligibility

Eligible Applicants: Public and State controlled institutions of higher education
City or township governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Public housing authorities/Indian housing authorities
State governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
For profit organizations other than small businesses
Small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
Special district governments
Private institutions of higher education
Independent school districts
Native American tribal governments (Federally recognized)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; See FOA for eligibility. Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to continue to follow the Epidemiology of Diabetes Interventions and Complications (EDIC) cohort through a collaborative cooperative agreement. EDIC is an observational study that was launched at the completion of the Diabetes Control and Complications Trial (DCCT) trial. The DCCT showed that intensive therapy significantly reduced the risk of diabetes complications compared to conventional therapy. At DCCT completion, all cohort members were taught intensive diabetes therapy. In 1994, EDIC was launched to: (1) evaluate the long-term effects of DCCT intensive therapy, (2) describe the long-term effects of glycemia and other risk factors on diabetes complications, and (3) characterize type 1 diabetes complications by supporting collaborative research to utilize the EDIC cohort as well as its data set and biologic/genetic samples. To date, EDIC has: (1) demonstrated a continued benefit of intensive therapy on the development and progression of diabetes complications and (2) characterized the development and progression of diabetes complications. The primary purpose of this FOA is to support the EDIC Biostatistics Research Center to continue follow-up of the EDIC cohort to study the development of complications and the longer term course of type 1 diabetes in a well characterized type 1 diabetes population, including but not limited to cardiovascular disease, mortality, severe microvascular disease (blindness, kidney failure, amputation), neurocognitive impairments, and physical fragility. The EDIC Biostatistics Research Center will manage and support EDIC operations and analyses, including but not limited to support of other EDIC core facilities and other subcontractors as well as provision of biostatistical design and analysis, data and sample management, quality control, dissemination, and public accessibility. RFA-DK-16-508 will support continuation of the EDIC Clinical Research Center.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-16-509.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-D Use for due dates on or after May 25, 2016 PKG00226290 Oct 08, 2016 Nov 08, 2016 View

Package 1

Mandatory forms

286802 RR_SF424_2_0-2.0.pdf

286802 PHS398_CoverPageSupplement_3_0-3.0.pdf

286802 RR_OtherProjectInfo_1_3-1.3.pdf

286802 PerformanceSite_2_0-2.0.pdf

286802 RR_KeyPersonExpanded_2_0-2.0.pdf

286802 PHS398_ResearchPlan_3_0-3.0.pdf

Optional forms

286802 RR_Budget_1_3-1.3.pdf

286802 RR_SubawardBudget30_1_3-1.3.pdf

286802 PHS398_ModularBudget_1_2-1.2.pdf

286802 PHS_Inclusion_Enrollment_Report-1.0.pdf

286802 PHS_AssignmentRequestForm-1.0.pdf

2025-07-09T17:56:25-05:00

Share This Post, Choose Your Platform!

About the Author: